Revolution Medicines Inc (RVMD)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: RVMD Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-03-24	2025-03-20	PS Planned sale	Cislini Jeff General Counsel Officer	2,041 -3.4% 38.71 USD 79,008	2,041 -3.4%	38.71	USD 79,008
2025-03-19	2025-03-17	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	3,294 -1.1% 39.04 USD 128,599	3,294 -1.1%	39.04	USD 128,599
2025-03-19	2025-03-17	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	11,738 -2.6% 39.04 USD 458,255	11,738 -2.6%	39.04	USD 458,255
2025-03-19	2025-03-17	PS Planned sale	Horn Margaret A Chief Operating Officer Officer	3,058 -2.0% 39.04 USD 119,385	3,058 -2.0%	39.04	USD 119,385
2025-03-19	2025-03-17	PS Planned sale	Cislini Jeff General Counsel Officer	1,458 -2.4% 39.04 USD 56,921	1,458 -2.4%	39.04	USD 56,921
2025-03-19	2025-03-17	PS Planned sale	Anders Jack Chief Financial Officer Officer	1,864 -1.6% 39.04 USD 72,771	1,864 -1.6%	39.04	USD 72,771
2025-01-22	2025-01-21	PS Planned sale	Cislini Jeff General Counsel Officer	2,406 -5.8% 40.50 USD 97,443	2,406 -5.8%	40.50	USD 97,443
2024-12-18	2024-12-16	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	11,714 -3.5% 45.40 USD 531,860	11,714 -3.5%	45.40	USD 531,860
2024-12-18	2024-12-16	PS Planned sale	Cislini Jeff General Counsel Officer	1,599 -3.7% 45.40 USD 72,601	1,599 -3.7%	45.40	USD 72,601
2024-12-18	2024-12-16	PS Planned sale	Horn Margaret A Chief Operating Officer Officer	4,329 -3.3% 45.40 USD 196,553	4,329 -3.3%	45.40	USD 196,553
2024-12-18	2024-12-16	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	4,663 -1.8% 45.40 USD 211,718	4,663 -1.8%	45.40	USD 211,718
2024-12-18	2024-12-16	PS Planned sale	Anders Jack Chief Financial Officer Officer	2,635 -2.7% 45.40 USD 119,639	2,635 -2.7%	45.40	USD 119,639
2024-12-09	2024-12-05	B Purchase	Schroeder Thilo Non-Executive Director	760,869 +inf% 46.00 USD 34,999,974	760,869 +inf%	46.00	USD 34,999,974
2024-12-09	2024-12-05	B Purchase	Schroeder Thilo Non-Executive Director	543,478 +35.0% 46.00 USD 24,999,988	543,478 +35.0%	46.00	USD 24,999,988
2024-11-19	2024-11-15	PS Planned sale	Cislini Jeff General Counsel Officer	2,554 -5.6% 55.13 USD 140,811	2,554 -5.6%	55.13	USD 140,811
2024-11-15	2024-11-13	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	2,888 -1.1% 59.45 USD 171,694	2,888 -1.1%	59.45	USD 171,694
2024-11-15	2024-11-13	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	13,778 -4.9% 58.49 USD 805,815	13,778 -4.9%	58.49	USD 805,815
2024-11-08	2024-11-06	PS Planned sale	Cislini Jeff General Counsel Officer	6,000 -11.6% 60.00 USD 360,000	6,000 -11.6%	60.00	USD 360,000
2024-11-05	2024-11-04	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	50,900 -14.5% 55.56 USD 2,827,821	50,900 -14.5%	55.56	USD 2,827,821
2024-11-05	2024-11-01	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,000 -19.7% 55.02 USD 275,105	5,000 -19.7%	55.02	USD 275,105
2024-11-05	2024-11-01	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,000 -19.7% 55.03 USD 275,134	5,000 -19.7%	55.03	USD 275,134
2024-11-05	2024-11-01	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	9,100 -2.9% 55.02 USD 500,714	9,100 -2.9%	55.02	USD 500,714
2024-11-04	2024-10-31	PS Planned sale	Patel Sushil Non-Executive Director	5,000 -20.0% 54.14 USD 270,715	5,000 -20.0%	54.14	USD 270,715
2024-10-16	2024-10-14	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	2,610 -1.0% 50.08 USD 130,702	2,610 -1.0%	50.08	USD 130,702
2024-10-16	2024-10-14	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	14,056 -5.0% 49.38 USD 694,102	14,056 -5.0%	49.38	USD 694,102
2024-10-15	2024-10-11	PS Planned sale	Horn Margaret A Chief Operating Officer Officer	50,000 -27.4% 50.34 USD 2,517,055	50,000 -27.4%	50.34	USD 2,517,055
2024-10-15	2024-10-11	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	30,000 -9.1% 50.36 USD 1,510,773	30,000 -9.1%	50.36	USD 1,510,773
2024-10-15	2024-10-11	PS Planned sale	Cislini Jeff General Counsel Officer	6,000 -11.6% 50.17 USD 301,027	6,000 -11.6%	50.17	USD 301,027
2024-10-15	2024-10-11	PS Planned sale	Anders Jack Chief Financial Officer Officer	10,000 -9.2% 50.30 USD 502,979	10,000 -9.2%	50.30	USD 502,979
2024-10-10	2024-10-08	PS Planned sale	Weber Barbara Non-Executive Director	5,200 -28.5% 48.02 USD 249,716	5,200 -28.5%	48.02	USD 249,716
2024-10-03	2024-10-01	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	2,022 -0.7% 45.46 USD 91,913	2,022 -0.7%	45.46	USD 91,913
2024-10-03	2024-10-01	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	7,978 -2.6% 44.80 USD 357,409	7,978 -2.6%	44.80	USD 357,409
2024-09-18	2024-09-16	PS Planned sale	Anders Jack Chief Financial Officer Officer	2,244 -2.2% 44.19 USD 99,152	2,244 -2.2%	44.19	USD 99,152
2024-09-18	2024-09-16	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	11,715 -3.8% 44.19 USD 517,631	11,715 -3.8%	44.19	USD 517,631
2024-09-18	2024-09-16	PS Planned sale	Cislini Jeff General Counsel Officer	1,454 -3.1% 44.19 USD 64,245	1,454 -3.1%	44.19	USD 64,245
2024-09-18	2024-09-16	PS Planned sale	Horn Margaret A Chief Operating Officer Officer	4,331 -3.2% 44.19 USD 191,367	4,331 -3.2%	44.19	USD 191,367
2024-09-18	2024-09-16	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	4,665 -1.7% 44.19 USD 206,124	4,665 -1.7%	44.19	USD 206,124
2024-09-16	2024-09-13	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	10,701 -3.8% 43.65 USD 467,045	10,701 -3.8%	43.65	USD 467,045
2024-09-16	2024-09-13	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	5,966 -2.1% 42.75 USD 255,042	5,966 -2.1%	42.75	USD 255,042
2024-08-15	2024-08-13	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	16,667 -5.8% 42.98 USD 716,389	16,667 -5.8%	42.98	USD 716,389
2024-08-02	2024-08-01	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	3,217 -1.0% 46.48 USD 149,519	3,217 -1.0%	46.48	USD 149,519
2024-08-02	2024-08-01	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	6,783 -2.1% 45.60 USD 309,308	6,783 -2.1%	45.60	USD 309,308
2024-07-17	2024-07-15	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	3,879 -1.4% 48.06 USD 186,420	3,879 -1.4%	48.06	USD 186,420
2024-07-17	2024-07-15	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	3,800 -1.4% 47.02 USD 178,683	3,800 -1.4%	47.02	USD 178,683
2024-07-17	2024-07-15	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	5,760 -2.0% 46.08 USD 265,406	5,760 -2.0%	46.08	USD 265,406
2024-07-17	2024-07-15	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	2,128 -0.7% 44.94 USD 95,622	2,128 -0.7%	44.94	USD 95,622
2024-07-17	2024-07-15	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	1,100 -0.4% 43.99 USD 48,384	1,100 -0.4%	43.99	USD 48,384
2024-07-16	2024-07-12	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,000 -16.4% 45.01 USD 225,059	5,000 -16.4%	45.01	USD 225,059
2024-07-16	2024-07-12	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,000 -16.4% 45.01 USD 225,058	5,000 -16.4%	45.01	USD 225,058
2024-07-16	2024-07-12	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	25,000 -7.4% 45.05 USD 1,126,205	25,000 -7.4%	45.05	USD 1,126,205
2024-07-10	2024-07-09	PS Planned sale	Patel Sushil Non-Executive Director	2,155 -9.7% 44.00 USD 94,820	2,155 -9.7%	44.00	USD 94,820
2024-07-10	2024-07-09	PS Planned sale	Cislini Jeff General Counsel Officer	2,399 -4.8% 40.83 USD 97,951	2,399 -4.8%	40.83	USD 97,951
2024-06-27	2024-06-26	PS Planned sale	Cislini Jeff General Counsel Officer	2,000 -3.9% 38.47 USD 76,940	2,000 -3.9%	38.47	USD 76,940
2024-06-26	2024-06-25	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	16,467 -5.8% 39.06 USD 643,152	16,467 -5.8%	39.06	USD 643,152
2024-06-26	2024-06-24	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	200 -0.1% 39.00 USD 7,800	200 -0.1%	39.00	USD 7,800
2024-06-20	2024-06-17	PS Planned sale	Anders Jack Chief Financial Officer Officer	1,893 -1.8% 37.39 USD 70,775	1,893 -1.8%	37.39	USD 70,775
2024-06-20	2024-06-17	PS Planned sale	Cislini Jeff General Counsel Officer	1,757 -3.3% 37.39 USD 65,690	1,757 -3.3%	37.39	USD 65,690
2024-06-20	2024-06-17	PS Planned sale	Horn Margaret A Chief Operating Officer Officer	4,415 -3.1% 37.39 USD 165,064	4,415 -3.1%	37.39	USD 165,064
2024-06-20	2024-06-17	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	11,950 -3.7% 37.39 USD 446,770	11,950 -3.7%	37.39	USD 446,770
2024-06-20	2024-06-17	PS Planned sale	Wei Lin Chief Medical Officer Officer	5,589 -7.3% 37.39 USD 208,954	5,589 -7.3%	37.39	USD 208,954
2024-06-20	2024-06-17	PS Planned sale	Kelsey Stephen Michael See Remarks Officer	3,349 -1.2% 37.39 USD 125,209	3,349 -1.2%	37.39	USD 125,209
2024-06-05	2024-06-03	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	901 -0.3% 40.93 USD 36,881	901 -0.3%	40.93	USD 36,881
2024-06-05	2024-06-03	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,699 -1.7% 39.99 USD 227,880	5,699 -1.7%	39.99	USD 227,880
2024-06-05	2024-06-03	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	900 -0.3% 39.09 USD 35,182	900 -0.3%	39.09	USD 35,182
2024-05-22	2024-05-21	PS Planned sale	Cislini Jeff General Counsel Officer	800 -1.5% 39.51 USD 31,605	800 -1.5%	39.51	USD 31,605
2024-05-22	2024-05-21	PS Planned sale	Cislini Jeff General Counsel Officer	700 -1.3% 38.67 USD 27,066	700 -1.3%	38.67	USD 27,066
2024-05-03	2024-05-03	PS Planned sale	Anders Jack Chief Financial Officer Officer	10,000 -8.9% 40.03 USD 400,260	10,000 -8.9%	40.03	USD 400,260
2024-04-12	2024-04-10	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,000 -14.1% 35.34 USD 176,687	5,000 -14.1%	35.34	USD 176,687
2024-04-12	2024-04-10	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,000 -14.1% 35.33 USD 176,659	5,000 -14.1%	35.33	USD 176,659
2024-04-12	2024-04-10	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	7,500 -1.6% 35.48 USD 266,122	7,500 -1.6%	35.48	USD 266,122
2024-04-12	2024-04-10	PS Planned sale	Patel Sushil Non-Executive Director	2,155 -12.1% 37.00 USD 79,735	2,155 -12.1%	37.00	USD 79,735
2024-03-28	2024-03-27	PS Planned sale	Cislini Jeff General Counsel Officer	800 -1.4% 31.52 USD 25,212	800 -1.4%	31.52	USD 25,212
2024-03-28	2024-03-27	PS Planned sale	Cislini Jeff General Counsel Officer	700 -1.3% 30.38 USD 21,269	700 -1.3%	30.38	USD 21,269
2024-03-20	2024-03-18	PS Planned sale	GOLDSMITH MARK A See Remarks Executive Director	5,788 -1.2% 31.58 USD 182,804	5,788 -1.2%	31.58	USD 182,804
2024-03-20	2024-03-18	PS Planned sale	Anders Jack Chief Financial Officer Officer	1,261 -1.2% 31.58 USD 39,826	1,261 -1.2%	31.58	USD 39,826

Revolution Medicines Inc (RVMD)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by